LMCG Investments’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-61,260
Closed -$6.93M 232
2025
Q1
$6.93M Buy
61,260
+5,311
+9% +$568K 0.46% 77
2024
Q4
$5.91M Buy
55,949
+9,484
+20% +$1.02M 0.36% 86
2024
Q3
$5.02M Sell
46,465
-7,212
-13% -$787K 0.3% 97
2024
Q2
$5.83M Sell
53,677
-12,876
-19% -$1.52M 0.34% 95
2024
Q1
$8.78M Buy
66,553
+52,282
+366% +$6.53M 0.52% 75
2023
Q4
$1.74M Hold
14,271
0.11% 164
2023
Q3
$1.6M Buy
14,271
+5,162
+57% +$656K 0.11% 170
2023
Q2
$1.33M Sell
9,109
-20
-0.2% -$2.72K 0.09% 197
2023
Q1
$1.18M Buy
9,129
+215
+2% +$27K 0.08% 203
2022
Q4
$1.14M Sell
8,914
-871
-9% -$101K 0.08% 200
2022
Q3
$1.02M Buy
9,785
+1,948
+25% +$214K 0.07% 221
2022
Q2
$823K Hold
7,837
0.06% 235
2022
Q1
$1M Buy
+7,837
New +$945K 0.06% 229
2015
Q3
$4.75M Hold
52,094
0.1% 307
2015
Q2
$5.53M Hold
52,094
0.12% 290
2015
Q1
$5.94M Sell
52,094
-103
-0.2% -$11.8K 0.12% 288
2014
Q4
$5.75M Hold
52,197
0.13% 267
2014
Q3
$5.09M Buy
52,197
+107
+0.2% +$10.5K 0.11% 272
2014
Q2
$5.25M Hold
52,090
0.11% 274
2014
Q1
$4.78M Hold
52,090
0.11% 272
2013
Q4
$4.71M Hold
52,090
0.1% 265
2013
Q3
$4.15M Sell
52,090
-1,803
-3% -$142K 0.1% 265
2013
Q2
$3.92M Buy
+53,893
New +$4.03M 0.1% 269

Other funds holding ZBH

LMCG Investments's ZBH Position: Q2 2025 in Review

LMCG Investments sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 61,260 shares — an estimated $6.93M sold.

LMCG Investments first reported a position in ZBH in Q2 2013 and held it in 23 quarters. The position peaked at $8.78M in Q1 2024. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • LMCG Investments reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • LMCG Investments sold 61,260 Zimmer Biomet shares in Q2 2025, an estimated $6.93M.
  • LMCG Investments first reported a position in Zimmer Biomet in Q2 2013 and held it in 23 quarters.
  • LMCG Investments's Zimmer Biomet position peaked at $8.78M in Q1 2024.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on LMCG Investments's 13F filing for Q2 2025, filed 24 Jul 2025.